Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients.

Marziali, M; Pugliese, P; Losardo, A A; Ribersani, M; Anastasi, E; Angeloni, A; Pavan, A; Gentile, G

Marziali, M; Pugliese, P; Losardo, A A; Ribersani, M; Anastasi, E; Angeloni, A; Pavan, A; Gentile, G.

Affiliation

Marziali M; Immunohematology and Transfusion Medicine Unit, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy.
Pugliese P; Immunohematology and Transfusion Medicine Unit, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy.
Losardo AA; Immunohematology and Transfusion Medicine Unit, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy.
Ribersani M; Hematology, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy.
Anastasi E; Department of Experimental Medicine, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy.
Angeloni A; Department of Experimental Medicine, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy.
Pavan A; Immunohematology and Transfusion Medicine Unit, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy.
Gentile G; Department of Translational and Precision Medicine, Sapienza Università di Roma, Rome, Italy.

Transfus Med ; 34(3): 238-240, 2024 Jun.

Article de En | MEDLINE | ID: mdl-38632665

Sujet(s)
Mots clés

Covid19; Efficacy; Safety; Thalassemia; Vaccine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thalassémie / Vaccin BNT162 Limites: Adolescent / Adult / Female / Humans / Male / Middle aged Langue: En Journal: Transfus Med Sujet du journal: HEMATOLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google